The effect 0/ age and sex on ED50 values for prop%l was studied in 92 patients aged between 16 and 85 years. All doses were based on lean tissue mass (LTM). The end-point/or loss 0/ consciousness was loss o/the ability to hold a light object. The mean o/the ED50 values/or males was 1.31 mg.kg LTM-I and/or females 1.28 mg.kg LTM-I. For males the ED50 values ranged/ram 0.94 to 1.69 mg.kg LTM-I. For females, the range was 1.06-1.57 mg.kg LTM-I. On statistical analysis, these differences were not significant. These data contrast with other studies in which dosage was based on total body mass where a decrease in dose requirement with age was demonstrated. We propose that by using lean tissue mass to calculate dosage, considerable normalisation 0/ patient response can be achieved. There is considerable inter-individual variation in response to prop%l. Age is less important than this variation in determining the correct dose/or each patient, provided doses are based on LTM.
It is well known that some elderly patients require a lower dose of an intravenous induction agent than younger patients when dosage is based on total body mass (TBM). I Possible mechanisms for this apparent decrease in dose requirement are changes in pharmacodynamic responses or an alteration in pharmacokinetics.
Thiopentone has been the drug studied in research on this issue to date. Despite the fact that brain mass is reduced in the elderly and that neurotransmitters are depleted, no decrease in brain sensitivity to thiopentone has been demonstrated. 2 Similarly, no difference in the thiopentone concentration producing a specific effect has been demonstrated with age. 3 A pharmacokinetic mechanism has been proposed for decreased dose requirements with increasing age. 4 . 5 There is a significant decrease in the clearance from the central compartment to the rapidly equilibrating compartment of thiopentone in the elderly and it has been suggested that this change is responsible for the decreased requirement for this drug when dosage is based on TBM. There are enough similarities in the physical properties of thiopentone and propofol to assume that these data can be applied to propofol.
Clearly, changes in body morphology are important. The decline in lean tissue mass with age in both men and women has been well documented. 6 ,7 Wolfsohn and Joshi 8 studied the value of calculated lean tissue mass (LTM) for deriving dosage of thiopentone. They demonstrated that patient responses were much more predictable if L TM rather than TBM was used and emphasised the concept of 'pharmacologically active mass'. Their statement that 'clinically predictable dose response to drugs must take into account the somatic characteristics of the patient ... ' appears to have done little to divert the larger body of anaesthetists and particularly researchers from calculating the dose of induction agents on the basis of the TBM of the patient. 9 In fact, no previous studies on the effect of age and sex on dose requirements of propofol have taken into account the percentage fat of the patients.
The aim of this study was to determine EDSO values for single doses ofpropofol administered on the basis of L TM, rather than TBM, in adult males and females through a wide range of ages, and then to analyse the data to assess the effect of age and sex on EDSO values.
METHODS
Patients aged between 16 and 85 years, undergoing surgery and of American Society of Anesthesiologists' physical status grades I, 11 or III were accepted for this study in accordance with a protocol approved by the Board of Medical Research of the Hospital.
All patients were premedicated approximately sixty minutes prior to induction with oral temazepam 10, 20 or 30 mg according to their LTM.
Males and females were separately grouped into the ten-year age groups so that a total of fourteen groups (seven male and seven female) were studied. Individual doses of propofol were based on LTM calculated from TBM (kg), height (cm) and girth at the umbilicus (cm) using a formula described by Wolfsohn and Joshi.8 Lignocaine 1% 0.5 ml was added to each dose of propofol in an attempt to reduce pain on injection.
Prior to drug administration each patient was placed in the supine position and a 22 gauge Jelco™ cannula was inserted in a forearm vein on one side. The patient was then asked to grasp a 20 ml plastic syringe filled with water between the thumb and index finger ofthe other hand with the palm facing the floor, the arm being supported in a comfortable position by a rest.
The dose of propofol was administered at a steady rate over fifteen seconds. A positive response was recorded if the patient dropped the syringe within ninety seconds of injection. Once the syringe had been dropped or the ninety-second period had elapsed, supplemental dosage was given to allow the anaesthetic to proceed in the normal way.
Individual patients were allocated to groups according to age and sex as they presented and in each case dosage was determined by their position in a sequence. Fifty per cent response levels (ED50) were calculated using the sequential up-and-down technique developed by Dixon lo and described in detail by Crankshaw and Allt-Graham. 11 Differences between ED50 values were evaluated statistically on the basis of the doses given to the final six patients in each sequence. with a control was used to compare ED50 values for the different age group in each test. 12 An unpaired two-tailed Student's t-test (with Bonferroni correction for multiple comparisons) was used to compare males and females. 13 Results are expressed as mean with standard deviation in parenthesis unless specified otherwise.
RESULTS
A total of 92 patients were included in the study. For men, the mean TBM was 73 (11) kg and the mean LTM 56 (7) kg while for females the mean TBM was 65 (10) kg and the mean LTM 44 (5) kg. There was a trend towards an increase in body fat with age ( Figure I) . Table I provides details of the age groups, sequence of responses, sizes of groups, average per cent fat, average lean tissue mass and the resulting ED50 values with 95% confidence intervals.
The mean ED50 value for males was 1.31 mg.kg LTM-I and forfemale 1.28 mg.kg LTM-I. There was a trend towards higher ED50 values in middle age but these differences were not significant for either sex. The ratio between the highest and the lowest ED50 value was 1.49 for females and 1.79 for males.
For the decades from 16 to 85 years the ED50 values of propofol for males and females were not significantly different. The highest male to female ratio of ED50 value was 1.27.
DISCUSSION
The ED50 values derived in this study were relatively uniform between males and females and for different age groups and closely approximated the value of 1.34 mg.kg LTM -I determined previously by probit analysis in a total of fifty-six patients. 14 The endpoints used in the study of potency have been compared l5 and dropping a light object has been found to be a more reliable method, with more relevance to the clinical situation, than either loss of eyelash reflex or cessation of counting. Also, it is a measure of loss of consciousness rather than reflex ablation.
The conventional method of estimating ED50 values for anaesthetic agents has been to derive a cumulative dose-response curve and utilize the probit analysis technique. The usefulness of this technique is limited, however, by the large numbers involved. The sequential up-and-down technique employs fewer patients, six being adequate to achieve maximum power and equivalent accuracy to conventional probit analysis. 10 By concentrating on the 50 per cent level the test is efficient for ED50 determination, but does not provide information on the slope of the dose-response relationship. We have not shown significant difference between ED50 values in males and females when dosage is based on L TM. In fact, the doses required are quite similar. As dosage based on lean tissue mass eliminates the differences between male and female body composition to a great extent, our result is expected.
Also, we have not demonstrated an age-related change in propofol ED50 values using LTM to calculate dosage. This contrasts with other workers who have shown a decreased dose requirement for propofol in the elderly when TBM is used. Using loss of verbal contact as the endpoint, Dundee et a{J showed that a dose of 2.25 to 2.50 mg.kg TBM-l was required for induction of patients under 60 years while 1. 5 to 1. 7 5 mg.kg TBM -1 was required for patients over 60. The requirement for supplemental doses based on TBM to maintain anaesthesia is also reduced in the elderly. 16 There is a greater degree of variability of response in the population to propofol than to thiopentone 14, 17. This is demonstrated by the steeper slope of the dose-response curve of thiopentone. 14 Therefore, in any pharmacodynamic study, the ability to detect the effects of factors such as age or sex on the ED50 of propofol is considerably less than for thiopentone.
Following from this, it would be wrong to assume that all elderly patients require a lower dose of propofol than younger patients. The variability in response to propofol will mean that some patients will be relatively resistant. Also, age only has a small influence on the lean mass of the patient, particularly in females.
This study demonstrates that use of L TM to calculate dosage largely eliminates the effects of changes in body morphology whether they be due to age or unrelated factors. It is clear that careful titration of the induction dose, based initially on L TM, is prudent to minimise the risk of unwanted side-effects.
We conclude that, for propofol, lean tissue mass quite accurately respresents the pharmacologically active mass of the patient and that dosing on the basis of lean tissue mass eliminates the previously observed differences in response between age groups and between the sexes. 
